Similar Articles
The Metabolic Syndrome: A Cancer Risk Factor?
Ayça Nur Demir, Kerem Can Tunç, Mehtap Odabaşı, Oytun Erbaş
DOI: 10.5606/jebms.2023.1040
Issue: 2023, Volume 4 - Issue 1
611
563
Emerging Immunotherapeutic Approaches for Managing Metastasis
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2023.1050
Issue: 2023, Volume 4 - Issue 2
530
479
Nasopharyngeal Carcinoma: Causes and Incidence
Fatih Özgür Sarıbıyık, Oytun Erbaş
DOI: 10.5606/jebms.2023.1060
Issue: 2023, Volume 4 - Issue 3
459
345
Regulatory T Cells and Their Implications in Cancer Immunotherapy
Saime Sıla Gemici, Oytun Erbaş
DOI: 10.5606/jebms.2023.1064
Issue: 2023, Volume 4 - Issue 3
357
380
Cancer Stem Cells
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2024.1083
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
411
303
Stem Cell Therapy in Cancer
Ayça Nur Demir, Oytun Erbaş
DOI: 10.5606/jebms.2024.1084
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
348
307
Complications of Gestational Diabetes: An Overview
Aybüke Erkul, Oytun Erbaş
DOI: 10.5606/jebms.2024.1087
Issue: 2024, Volume 5 - Issue 2
308
586
Enteral Nutrition in Cancer Patients
Gamze Nur Yüksel, Oytun Erbaş
DOI: 10.5606/jebms.2024.1089
Issue: 2024, Volume 5 - Issue 2
277
424
Coffee Intake and Cancer Risk: Exploring the Relationship
Zehra Betül Aydın, Oytun Erbaş
DOI: 10.5606/jebms.2024.1091
Issue: 2024, Volume 5 - Issue 2
285
418
Aspirin and NSAIDs as Cancer Preventive Agents: A Review
Nadin Bedikyan, Oytun Erbaş
DOI: 10.5606/jebms.2024.1093
Issue: 2024, Volume 5 - Issue 2
293
428